Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-034842
Filing Date
2022-11-02
Accepted
2022-11-02 21:02:26
Documents
1
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 23070
  Complete submission text file 0000899243-22-034842.txt   24474
Mailing Address C/O GOOGLE VENTURES 2011, L.P. 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address
Yeshwant Krishna (Reporting) CIK: 0001585001 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40489 | Film No.: 221355869

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations